Clinical trial

MRI Sarcoma Non Invasive Thermometry

NCT00093509 · Mark Dewhirst, Other · Completed

Key facts

NCT number NCT00093509
Title MRI Sarcoma Non Invasive Thermometry
Official title Magnetic Resonance Based Non-Invasive Thermometry for Hyperthermic Treatment of Extremity Soft Tissue Sarcomas: A Multimodal Phase I/II Study
Lead sponsor Mark Dewhirst, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Sarcoma
Intervention type Drug, Procedure, Radiation
Interventions doxorubicin hydrochloride, ifosfamide and mesna, hyperthermia treatment with an MRI Compatible Radiofrequency Extremity Hyperthermia Applicator, radiation therapy
Enrollment 15
Start date Nov 1, 1999
Primary completion Jul 1, 2007
Completion Oct 1, 2009
First posted Oct 8, 2004
Last update posted Sep 1, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies